as on October 14, 2025 at 1:29 am IST
Day's Low
Day's High
1.11%
Downside
-0.10%
Upside
52 Week's Low
52 Week's High
8.57%
Downside
23.19%
Upside
Check Sanofi market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$120.2B
EPS (TTM)
4.5911
Dividend Yield
3.62%
Quarterly Earnings Growth YOY
2.67%
PE Ratio (TTM)
16.03
Industry PE ratio
19.200384615384614
PEG Ratio
0.773
EBITDA
12.1B
Revenue (TTM)
45.7B
Profit Margin
19.95%
Return On Equity TTM
9.00%
Track how Sanofi P/E has moved over time to understand its valuation trends.
Sanofi in the last 5 years
Lowest (8.47x)
December 31, 2023
Today (16.03x)
October 13, 2025
Industry (19.20x)
October 13, 2025
Highest (14.50x)
June 30, 2021
Today’s Price to Earnings Ratio: 16.03x
Compare market cap, revenue, PE, and other key metrics of Sanofi with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $120.2B | -6.57% | 16.03 | 19.95% | |
BUY | $747.2B | 455.36% | 54.33 | 25.91% | |
BUY | $407.2B | 162.44% | 109.76 | 6.45% | |
BUY | $459.3B | 28.55% | 20.4 | 25.00% | |
BUY | $259.4B | 55.59% | 14.63 | 35.61% |
The Sanofi stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Sanofi investment value today
Current value as on today
₹94,398
Returns
Returns from Sanofi Stock
Dollar Returns*
₹5,606 (+5.61%)
Based on 31 analysts
74.19%
Buy
22.58%
Hold
3.23%
Sell
Based on 31 analysts, 74.19% of analysts recommend a 'BUY' rating for Sanofi. Average target price of $61.5
Get share price movements and forecasts by analysts on Sanofi.
What analysts predicted
20.65%UPSIDE
Target Price
$61.5
Current Price
$48.8
Analyzed by
31 Analysts
Target
$61.50
Sanofi target price $61.5, a slight upside of 20.65% compared to current price of $48.8. According to 31 analysts rating.
Investment in Sanofi Shares on INDmoney has dropped by -36.30% over the past 30 days, indicating reduced transactional activity.
Time period: to
Search interest for Sanofi Stock has decreased by -17% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 07 October
Tue, 04:30 PM
-Novavax transfers marketing authorization for Nuvaxovid vaccine to Sanofi in the EU, granting full commercial responsibility.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Sanofi has shown positive revenue trends over the last three quarters. Its revenue increased from $7.63 billion to $10.73 billion, reflecting an average growth of 14.6% per quarter.
Profit Spike
Sanofi has shown strong performance in its net profit over the last three quarters. The net profit increased from $499.0 million to $3.94 billion, demonstrating a remarkable average growth of 62.9% per quarter.
Price Rise
In the last 1 month, SNY stock has moved up by 2.3%
Against Peers
In the last 3 years, Eli Lilly And Company has given 61.3% return, outperforming this stock by 40.8%
Against Peers
In the last 1 year, Abbvie Inc has given 18.7% return, outperforming this stock by 31.2%
Organisation | Sanofi |
Headquarters | 46, avenue de la Grande Armée, Paris, France, 75017 |
Industry | Health Technology |
CEO | Mr. Paul Hudson |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Olivier Charmeil | Executive Vice President of General Medicines |
Fabrizio Gaudi | Head of Austrian, German & Swiss Operations |
Mr. Paul Hudson | CEO & Director |
Ms. Madeleine Roach | Executive VP & Head of Business Operations |
Ms. Natalie Bickford | Executive VP & Chief People Officer |
Mr. Pierre Chancel | Senior Vice President of Global Diabetes and Senior Vice President of Global Marketing |
Mr. Felix Lauscher | Head of IR North America & Asia |
Mr. François-Xavier Roger | Executive VP & CFO |
Mr. Thomas Kudsk Larsen | Head of Investor Relations |
Mr. Roy Papatheodorou | Executive VP & General Counsel |
Sanofi share price today is $48.8 as on at the close of the market. Sanofi share today touched a day high of $48.75 and a low of $48.26.
Sanofi share touched a 52 week high of $60.12 on and a 52 week low of $44.62 on . Sanofi stock price today i.e. is closed at $48.8,which is 18.82% down from its 52 week high and 9.38% up from its 52 week low.
Sanofi market capitalisation is $0.12T as on .
Indian investors can start investing in Sanofi (SNY) shares with as little as ₹88.635 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.35 in Sanofi stock (as per the Rupee-Dollar exchange rate as on ).
Based on Sanofi share’s latest price of $48.8 as on October 14, 2025 at 1:29 am IST, you will get 0.2049 shares of Sanofi. Learn more about
fractional shares .
Sanofi stock has given -6.57% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?